Abstract

Research Article

Surgical Management of Uterine Fibroids at the Teaching Hospital of Angre Abidjan Cote d’Ivoire: 193 Cases Report

Gbary-Lagaud Eléonore*, Houphouet-Mwandji Carine, Effoh Denis and Adjoby Roland

Published: 20 June, 2023 | Volume 6 - Issue 2 | Pages: 076-081

Objective: To evaluate the surgical management of myomas at the Teaching Hospital of Angré according to the FIGO (International Federation of Gynecology and Obstetrics) classification.
Patients and methods: This was a cross-sectional study at the Teaching Hospital of Angre from January 1, 2020, to December 31, 2022. Patients whose operative indication was clearly identified were included in the study. Incomplete files were not included. The variables studied were anthropometric parameters, clinical characteristics of myomas, and surgery. Due to the large size and multifocal location of uterine myomas, the therapeutic option remained surgery by laparotomy.
Results: Most patients were over 35 years old (71.5%) and nulliparous (52.8%). The first indication for surgery was menometrorrhagia (88.6%), followed by the desire for motherhood (37.8%) and dysmenorrhoea (20.2%) for myomas most often FIGO type 4 (p = 0.0031). Myomectomy under cervical-isthmic tourniquet was the most common procedure for FIGO type 4 myomas (66.1%; p = 0.0543). Hysterectomy was most frequently performed for FIGO type 7 myomas (43.9%; p = 0.0543). For myomectomy, the first complication was anaemia (3.5%) followed by uterine suture haemorrhage (1.7%) (p = 0.5139).
Conclusion: Our surgical practice at the Teaching Hospital of Angre is in accordance with FIGO recommendations. However, an effort should be made to promote the minimally invasive surgical approach (laparoscopic, hysteroscopic, transvaginal ablation) for small fibroids (≤ 5 cm) or FIGO type 0 to 3, which is not very frequent in our current practice.

Read Full Article HTML DOI: 10.29328/journal.cjog.1001132 Cite this Article Read Full Article PDF

References

  1. Fernandez H, Chabbert Buffet N, Allouche S. Prévalence du fibrome utérin en France et impact sur la qualité de vie à partir d'une enquête menée auprès de 2500 femmes de 30-55ans [Prevalence of uterine fibroids in France and impact on quality of life: results of a survey among 2500 women between 30-55 years]. J Gynecol Obstet Biol Reprod (Paris). 2014 Nov;43(9):721-7. French. doi: 10.1016/j.jgyn.2014.07.006. Epub 2014 Aug 11. PMID: 25124196.
  2. Lansac J, Lecomte P, Marret H. Gynecology for the practitioner. Elsevier Masson SAS. 2012; 8: 65-80.
  3. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003 Jan;188(1):100-7. doi: 10.1067/mob.2003.99. PMID: 12548202.
  4. Okogbo FO, Ezechi OC, Loto OM, Ezeobi PM. Uterine Leiomyomata in South Western Nigeria: a clinical study of presentations and management outcome. Afr Health Sci. 2011 Jun;11(2):271-8. PMID: 21857861; PMCID: PMC3158515.
  5. Racinet C. Epidemiology, risk factors and symptomatology of uterine myomas. MT Reproductive Medicine Gynecology Endocrinology. 2009; 11, 2: 118-122.
  6. Chalal N, Demmouche A. Profil épidémiologique des fibromes utérins dans la région de Sidi Bel Abbes, Algérie [Epidemiological profile of uterine fibroids in the region of Sidi Bel Abbes, Algeria]. Pan Afr Med J. 2013 May 6;15:7. French. doi: 10.11604/pamj.2013.15.7.2690. PMID: 23847704; PMCID: PMC3708320.
  7. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Gynecology. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. Obstet Gynecol. 2021 Jun 1;137(6):e100-e115. doi: 10.1097/AOG.0000000000004401. PMID: 34011888.
  8. Clevenger-Hoeft M, Syrop CH, Stovall DW, Van Voorhis BJ. Sonohysterography in premenopausal women with and without abnormal bleeding. Obstet Gynecol. 1999 Oct;94(4):516-20. doi: 10.1016/s0029-7844(99)00345-2. PMID: 10511351.
  9. Munro MG, Critchley HO, Broder MS, Fraser IS; FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011 Apr;113(1):3-13. doi: 10.1016/j.ijgo.2010.11.011. Epub 2011 Feb 22. PMID: 21345435.
  10. High Authority of Health. Non-drug treatments for uterine fibroids. Relevance sheet March. 2022; 1-9.
  11. Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2014 Dec 26;(12):CD005073. doi: 10.1002/14651858.CD005073.pub4. PMID: 25541260.
  12. National Institute for Health and Care Excellence. Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids. Interventional procedures guidance. London: NICE; 2021. https://www.nice.org.uk/guidance/ipg689/resources/transcervic al-ultrasoundguided-radiofrequencyablation-for-symptomaticuterine-fibroids-pdf 1899874353838021 Ref ID: 51
  13. Vilos GA, Allaire C, Laberge PY, Leyland N; SPECIAL CONTRIBUTORS. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8. PMID: 25767949.
  14. Sunkara SK, Khairy M, El-Toukhy T, Khalaf Y, Coomarasamy A. The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis. Hum Reprod. 2010 Feb;25(2):418-29. doi: 10.1093/humrep/dep396. Epub 2009 Nov 12. PMID: 19910322.
  15. Zepiridis LI, Grimbizis GF, Tarlatzis BC. Infertility and uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2015; S1521 6934: 00235-00237.
  16. Gupta S, Jose J, Manyonda I. Clinical presentation of fibroids. Best Pract Res Clin Obstet Gynaecol. 2008 Aug;22(4):615-26. doi: 10.1016/j.bpobgyn.2008.01.008. Epub 2008 Mar 26. PMID: 18372219.
  17. Marsh EE, Al-Hendy A, Kappus D, Galitsky A, Stewart EA, Kerolous M. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women. J Womens Health (Larchmt). 2018 Nov;27(11):1359-1367. doi: 10.1089/jwh.2018.7076. Epub 2018 Sep 19. PMID: 30230950; PMCID: PMC6247381.
  18. Berujon E, Thubert T, Fauvet R, Villot A, Pizzoferrato AC. Impact of uterine fibroid surgery on lower urinary tract symptoms. J Gynecol Obstet Hum Reprod. 2022 May;51(5):102355. doi: 10.1016/j.jogoh.2022.102355. Epub 2022 Mar 13. PMID: 35296450.
  19. Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril. 2009 Apr;91(4):1215-23. doi: 10.1016/j.fertnstert.2008.01.051. Epub 2008 Mar 12. PMID: 18339376.
  20. Wallace K, Zhang S, Thomas L, Stewart EA, Nicholson WK, Wegienka GR, Wise LA, Laughlin-Tommaso SK, Diamond MP, Marsh EE, Jacoby VL, Anchan RM, Venable S, Larry GM, Lytle B, Wang T, Myers ER. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids. Fertil Steril. 2020 Mar;113(3):618-626. doi: 10.1016/j.fertnstert.2019.10.028. PMID: 32192594.
  21. Allameh Z, Afzali S, Jafarpisheh M, Movahedi M, Mousavi Seresht L. Evaluation of the Efficacy and Complications of Uterine Artery Embolization in Comparison with Laparotomy-Myomectomy in the Treatment of Uterine Myomas: A Randomized Clinical Trial. Med J Islam Repub Iran. 2022 Aug 3;36:87. doi: 10.47176/mjiri.36.87. PMID: 36128265; PMCID: PMC9448452.
  22. Petraglia F, Serour GI, Chapron C. The changing prevalence of infertility. Int J Gynaecol Obstet. 2013 Dec;123 Suppl 2:S4-8. doi: 10.1016/j.ijgo.2013.09.005. Epub 2013 Sep 7. PMID: 24112745.
  23. Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020 Apr;149(1):3-9. doi: 10.1002/ijgo.13102. Epub 2020 Feb 17. PMID: 31960950.
  24. Li S, Chen B, Sheng B, Wang J, Zhu X. The associations between serum vitamin D, calcium and uterine fibroids in Chinese women: a case-controlled study. J Int Med Res. 2020 May;48(5):300060520923492. doi: 10.1177/0300060520923492. PMID: 32458705; PMCID: PMC7273764.
  25. Ciebiera M, Włodarczyk M, Ciebiera M, Zaręba K, Łukaszuk K, Jakiel G. Vitamin D and Uterine Fibroids-Review of the Literature and Novel Concepts. Int J Mol Sci. 2018 Jul 14;19(7):2051. doi: 10.3390/ijms19072051. PMID: 30011902; PMCID: PMC6073230.
  26. Vergara D, Catherino WH, Trojano G, Tinelli A. Vitamin D: Mechanism of Action and Biological Effects in Uterine Fibroids. Nutrients. 2021 Feb 11;13(2):597. doi: 10.3390/nu13020597. PMID: 33670322; PMCID: PMC7917888.
  27. Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. 2018 Jan;46:3-11. doi: 10.1016/j.bpobgyn.2017.09.004. Epub 2017 Oct 1. PMID: 29054502.
  28. Bradley LD, Pasic RP, Miller LE. Clinical Performance of Radiofrequency Ablation for Treatment of Uterine Fibroids: Systematic Review and Meta-Analysis of Prospective Studies. J Laparoendosc Adv Surg Tech A. 2019 Dec;29(12):1507-1517. doi: 10.1089/lap.2019.0550. Epub 2019 Nov 8. PMID: 31702440; PMCID: PMC7387230.
  29. Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016 Nov;22(6):665-686. doi: 10.1093/humupd/dmw023. Epub 2016 Jul 27. PMID: 27466209; PMCID: PMC5853598.
  30. Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril. 2009 Apr;91(4):1215-23. doi: 10.1016/j.fertnstert.2008.01.051. Epub 2008 Mar 12. PMID: 18339376.
  31. Fortin C, Flyckt R, Falcone T. Alternatives to hysterectomy: The burden of fibroids and the quality of life. Best Pract Res Clin Obstet Gynaecol. 2018 Jan;46:31-42. doi: 10.1016/j.bpobgyn.2017.10.001. Epub 2017 Oct 20. PMID: 29157931.
  32. Racine AC, Deffieux X, Debodinance P, Mezzadri M, Gervaise A, Boussion F, Catala L, Faivre E, Lefèbvre-Lacoeuille C, Sentilhès L, Fernandez H, Descamps P. Conservative treatment of fibroids with GynOcclude. National College of French Gynecologists and Obstetricians Extract from Updates in Gynecology and Obstetrics TOME. 2008; 32: 195-210.
  33. Istre O. Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy. Best Pract Res Clin Obstet Gynaecol. 2008 Aug;22(4):735-47. doi: 10.1016/j.bpobgyn.2008.01.010. Epub 2008 Mar 7. PMID: 18328788.
  34. Marshburn PB, Matthews ML, Hurst BS. Uterine artery embolization as a treatment option for uterine myomas. Obstet Gynecol Clin North Am. 2006 Mar;33(1):125-44. doi: 10.1016/j.ogc.2005.12.009. PMID: 16504811.
  35. Ordás P, Spagnolo E, Fernández LG, Diestro Tejeda MD, Lafuente P, Salas P, Lopez Carrasco A, Carbonell M, Hernández A. Comparison of surgical and obstetric outcomes in women with uterine leiomyomas after laparoscopic vs. abdominal myomectomy: A single-center cohort study. Front Surg. 2022 Dec 26;9:997078. doi: 10.3389/fsurg.2022.997078. PMID: 36636585; PMCID: PMC9831055.
  36. Metwally M, Raybould G, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev. 2020 Jan 29;1(1):CD003857. doi: 10.1002/14651858.CD003857.pub4. PMID: 31995657; PMCID: PMC6989141.
  37. Bettocchi S, Ceci O, Nappi L, Di Venere R, Masciopinto V, Pansini V, Pinto L, Santoro A, Cormio G. Operative office hysteroscopy without anesthesia: analysis of 4863 cases performed with mechanical instruments. J Am Assoc Gynecol Laparosc. 2004 Feb;11(1):59-61. doi: 10.1016/s1074-3804(05)60012-6. PMID: 15104833.
  38. Vilos GA, Allaire C, Laberge PY, Leyland N; SPECIAL CONTRIBUTORS. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8. PMID: 25767949.
  39. Shifrin G, Engelhardt M, Gee P, Pschadka G. Transcervical fibroid ablation with the Sonata™ system for treatment of submucous and large uterine fibroids. Int J Gynaecol Obstet. 2021 Oct;155(1):79-85. doi: 10.1002/ijgo.13638. Epub 2021 Mar 17. PMID: 33544889; PMCID: PMC8518813.
  40. Bhave Chittawar P, Franik S, Pouwer AW, Farquhar C. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2014 Oct 21;(10):CD004638. doi: 10.1002/14651858.CD004638.pub3. PMID: 25331441.
  41. Roust SP, Ouly FJ, Lopes P. Are the complications of hysterectomy related to the approach?. National College of French Gynecologists and Obstetricians Extract from Updates in Medical Gynecology. 2004; 183-208.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?